Lei S.

Experience

1. CEO of Apeloa Pharma Solutions, an Us Subsidiary of Apeloa Pharmaceuticals

   Apeloa Pharmaceutical

   Jul 2021 — Present · Boston, MA, US

   As a wholly owned subsidiary of Apeloa Pharmaceuticals, Apeloa Pharma Solutions (APS) runs as a CRO/CDMO R&D site in Greater Boston area to provide synthesis service to our pharmaceutical industry clients locally. Apeloa Pharmaceuticals Co, Ltd. is a Zhejiang-headquartered public listed pharmaceuticals company with multibillion USD market value, including three business sectors of API, CDMO, and Finished Dosage Form (FDF) to supply drug substances and drug products for global clients. Besides 7 commercial production facilities well in place in Zhejiang, Shandong, and Anhui province, the company has set up API technology center, CDMO R&D center, and pharmaceutical research institute in Hengdian headquarter, Shanghai, Boston, and Hangzhou. With state of art CDMO centers and production facilities China, Apeloa has built a long-term strategic cooperative relationship with domestic and overseas big pharma and biotech companies, grew a broad clients base globally, and reached 1.21 billion USD sales in the year of 2020.Together with all the other sites at Apeloa, APS is creating a collaborative and productive working model to connect all the experience-rich scientists in various locations and with different culture background into a team for Apeloa’s strategic goal as “Technology for